Androgens play an important role in cancer development and progression. Androgens exert their effects through activation of the androgen receptor. Although androgen receptor expression is lost following androgen deprivation therapy that induces clinical remission in most patients, androgen-independent prostate cancers express levels of androgen- receptor protein similar to those found in androgen-dependent prostate cancer and benign hyperplasia. This observation suggests that the androgen receptor may be as important for growth regulation in androgen-independent prostate cancer as it is in androgen-dependent prostate cancer and benign hyperplasia. Since prostate cancer develops more frequently and is more aggressive in African Americans than in Caucasians and, if the androgen receptor is critical for the regulation of proliferation of prostate cancer,, the importance of the androgen receptor should be even more apparent in African American than in Caucasian prostatic tissues. Yet, few if any, studies of the androgen receptor include tissues from African Americans. We will test the hypothesis that changes in the expression and function of the androgen receptor are critical to the progression. of prostate cancer and that these changes may differ between Caucasian and African Americans.
In Aim 1, we will use automated video image analysis to compare androgen receptor expression and tissue levels of potential activators of the androgen receptor in androgen dependent versus androgen-independent prostate cancer in Caucasian versus American Americans.
In Aim 2, we will search for molecular alterations in the androgen receptor gene in these same research specimens and determine whether these changes affected androgen receptor expression. Point mutations in the androgen receptor will be screened for using denaturing gradient gel electrophoresis and single stranded conformational polymorphism. Transient co-transfection assays will determine the functional characteristics of the mutant androgen receptors. The lengths of the glutamine and glycine repeat regions of exon A will be determined by direct sequencing.
In Aim 3, analysis of serial biopsies of prostate cancer from patients treated by castration will allow temporal comparison of androgen receptor protein expression, molecular changes in the androgen receptor and cellular proliferation Tissue from the time of onset of proliferation will be used to explore potential mechanisms of androgen receptor activation and expression of androgen-regulated genes developed in the androgen-dependent CWR22 human prostate cancer xenograft and the regenerating rat prostate in Projects 2 and 3, respectively.. Insights gained should allow a more complete understanding of the role of the androgen receptor in the development of androgen-independent prostate cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA077739-04
Application #
6484137
Study Section
Project Start
2001-08-01
Project End
2002-07-31
Budget Start
Budget End
Support Year
4
Fiscal Year
2001
Total Cost
$208,271
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
078861598
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Li, Qiuhui; Deng, Qu; Chao, Hsueh-Ping et al. (2018) Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses. Nat Commun 9:3600
Fiandalo, Michael V; Wilton, John H; Mantione, Krystin M et al. (2018) Serum-free complete medium, an alternative medium to mimic androgen deprivation in human prostate cancer cell line models. Prostate 78:213-221
Komisarof, Justin; McCall, Matthew; Newman, Laurel et al. (2017) A four gene signature predictive of recurrent prostate cancer. Oncotarget 8:3430-3440
Su, Shifeng; Chen, Xiaoyu; Geng, Jiang et al. (2017) Melanoma antigen-A11 regulates substrate-specificity of Skp2-mediated protein degradation. Mol Cell Endocrinol 439:1-9
Itkonen, Harri M; Brown, Michael; Urbanucci, Alfonso et al. (2017) Lipid degradation promotes prostate cancer cell survival. Oncotarget 8:38264-38275
Askew, Emily B; Bai, Suxia; Parris, Amanda B et al. (2017) Androgen receptor regulation by histone methyltransferase Suppressor of variegation 3-9 homolog 2 and Melanoma antigen-A11. Mol Cell Endocrinol 443:42-51
Stocking, John J; Fiandalo, Michael V; Pop, Elena A et al. (2016) Characterization of Prostate Cancer in a Functional Eunuch. J Natl Compr Canc Netw 14:1054-60
Frasinyuk, Mykhaylo S; Mrug, Galyna P; Bondarenko, Svitlana P et al. (2016) Antineoplastic Isoflavonoids Derived from Intermediate ortho-Quinone Methides Generated from Mannich Bases. ChemMedChem 11:600-11
Minges, John T; Grossman, Gail; Zhang, Ping et al. (2015) Post-translational Down-regulation of Melanoma Antigen-A11 (MAGE-A11) by Human p14-ARF Tumor Suppressor. J Biol Chem 290:25174-87
Montecinos, Viviana P; Morales, Claudio H; Fischer, Thomas H et al. (2015) Selective targeting of bioengineered platelets to prostate cancer vasculature: new paradigm for therapeutic modalities. J Cell Mol Med 19:1530-7

Showing the most recent 10 out of 103 publications